He joined ICG in 2009 and his clients have included Bristol-Myers Squibb, Sanofi, Myeloma UK, the General Dental Council, International SOS and Universities UK. In healthcare, his area of expertise is market access, particularly in cancer, where he has supported a number of successful campaigns working in the Westminster, Holyrood and European parliaments.
Daniel previously worked in the policy and government affairs team at global pharmaceutical company Merck Sharp & Dohme. At MSD, he briefed the senior management on key NHS and industry policy developments.
He completed his undergraduate studies in Russian and Politics at Edinburgh University before working and teaching for the British Council in Russia.